Overview
Convatec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence care and infusion care. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec's additional products include ostomy
...
Read More pouching systems, which allow patients with artificial openings (or stomas) to dispose of bodily waste into attachable pouches. Its products are sold in more than 100 countries, but generates about 95% of revenue from outside of the UK.
Read Less
Read More pouching systems, which allow patients with artificial openings (or stomas) to dispose of bodily waste into attachable pouches. Its products are sold in more than 100 countries, but generates about 95% of revenue from outside of the UK.
Read Less
Heather Lynn Mason
See more contacts
Other Personal Services
,
Personal and Laundry Services
,
Other Services (except Public Administration)
,
Miscellaneous personal service
Automotive Repair and Maintenance
,
Business, Professional, Labor, Political, and Similar Organizations
,
Civic and Social Organizations
,
Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
,
Death Care Services
,
Drycleaning and Laundry Services
,
Electronic and Precision Equipment Repair and Maintenance
,
Grantmaking and Giving Services
View more , Personal Care Services , Personal and Household Goods Repair and Maintenance , Private Households , Religious Organizations Social Advocacy Organizations
View fewer
View more , Personal Care Services , Personal and Household Goods Repair and Maintenance , Private Households , Religious Organizations Social Advocacy Organizations
View fewer
?
$2.29 billion
Actual
6.85%
46.2%
$3,515
DEC
?
?
London SETS:CTEC
Contacts
Get in Touch with 10 Principals* and 71 Contacts
-
Heather Lynn MasonDirector
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$2.29 billion
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $396 | $367 | $282 |
| Net Investing Cash | -$161 | -$286 | -$348 |
| Net Financing Cash | -$264 | -$124 | -$237 |
| Net Change in Cash | -$28 | -$42 | -$304 |
| Cash at Beginning of Period | $98 | $144 | $463 |
| Cash at End of Period | $65 | $98 | $144 |
| Capital Expenditure | -$122 | -$129 | -$144 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $65 | $98 | $144 |
| Accounts Receivable | $267 | $270 | $285 |
| Inventories | $350 | $396 | $337 |
| Other Current Assets | $112 | $106 | $124 |
| Asset Summary | |||
| Total Current Assets | $793 | $870 | $889 |
| Tangible Fixed Assets | $570 | $548 | $480 |
| Intangible Assets | $806 | $935 | $925 |
| Total Assets | $3,515 | $3,714 | $3,592 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $125 | $137 | $112 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $387 | $400 | $421 |
| Liability Summary | |||
| Total Current Liabilities | $512 | $536 | $533 |
| Long-Term Debt | $1,123 | $1,227 | $1,212 |
| Other Long-Term Liabilities | $17 | $68 | $ |
| Total Liabilities | $1,826 | $2,021 | $1,982 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $252 | $252 | $251 |
| Retained Earnings | -$828 | -$889 | -$892 |
| Equity Summary | |||
| Total Equity | $1,689 | $1,693 | $1,610 |
| Shares Outstanding | 2,044,344,893 | 2,045,802,962 | 2,043,872,048 |